Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Seribantumab in patients with NRG1+ locally advanced or metastatic solid tumors

A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors

Disease Types: Solid Tumors

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

 A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors 

For More Information:

https://clinicaltrials.gov/ct2/show/NCT04383210?cond=A+Phase+2+Study+of+Seribantumab+in+Adult+Patients+with+Neuregulin-1+%28NRG1%29+Fusion+Positive+Locally+Advanced+or+Metastatic+Solid+Tumors&draw=2&rank=1